Novavax Current Valuation vs. Shares Outstanding
| NVAX Stock | USD 8.47 0.43 5.35% |
For Novavax profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Novavax to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Novavax utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Novavax's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Novavax over time as well as its relative position and ranking within its peers.
Novavax |
Novavax's Revenue Breakdown by Earning Segment
Check out Correlation Analysis.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Novavax. If investors know Novavax will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Novavax listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.709 | Earnings Share (2.18) | Revenue Per Share 6.186 | Quarterly Revenue Growth (0.55) | Return On Assets (0.11) |
The market value of Novavax is measured differently than its book value, which is the value of Novavax that is recorded on the company's balance sheet. Investors also form their own opinion of Novavax's value that differs from its market value or its book value, called intrinsic value, which is Novavax's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Novavax's market value can be influenced by many factors that don't directly affect Novavax's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Novavax's value and its price as these two are different measures arrived at by different means. Investors typically determine if Novavax is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Novavax's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Novavax Shares Outstanding vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Novavax's current stock value. Our valuation model uses many indicators to compare Novavax value to that of its competitors to determine the firm's financial worth. Novavax is regarded fourth in current valuation category among its peers. It is regarded fifth in shares outstanding category among its peers creating about 0.24 of Shares Outstanding per Current Valuation. The ratio of Current Valuation to Shares Outstanding for Novavax is roughly 4.25 . Common Stock Shares Outstanding is likely to rise to about 105.8 M in 2024. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Novavax's earnings, one of the primary drivers of an investment's value.Novavax's Earnings Breakdown by Geography
Novavax Current Valuation vs. Competition
Novavax is regarded fourth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 251.97 Billion. Novavax adds roughly 680.54 Million in current valuation claiming only tiny portion of equities under Health Care industry.
Novavax Shares Outstanding vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Novavax |
| = | 680.54 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Novavax |
| = | 160.18 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Novavax Shares Outstanding Comparison
Novavax is currently under evaluation in shares outstanding category among its peers.
Novavax Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Novavax, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Novavax will eventually generate negative long term returns. The profitability progress is the general direction of Novavax's change in net profit over the period of time. It can combine multiple indicators of Novavax, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 2.7 M | 2.9 M | |
| Operating Income | -566.5 M | -538.2 M | |
| Income Before Tax | -543 M | -515.9 M | |
| Total Other Income Expense Net | 23.5 M | 24.7 M | |
| Net Loss | -545.1 M | -517.8 M | |
| Income Tax Expense | 2 M | 1.8 M | |
| Net Loss | -548.9 M | -576.4 M | |
| Non Operating Income Net Other | -7.9 M | -7.5 M | |
| Net Loss | -592.1 M | -562.5 M | |
| Interest Income | 13.9 M | 8 M | |
| Net Interest Income | -14.9 M | -15.6 M | |
| Change To Netincome | 660.2 M | 693.2 M | |
| Net Loss | (5.41) | (5.68) | |
| Income Quality | 1.32 | 0.86 | |
| Net Income Per E B T | 1.00 | 0.80 |
Novavax Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Novavax. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Novavax position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Novavax's important profitability drivers and their relationship over time.
Use Novavax in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Novavax position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novavax will appreciate offsetting losses from the drop in the long position's value.Novavax Pair Trading
Novavax Pair Trading Analysis
The ability to find closely correlated positions to Novavax could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Novavax when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Novavax - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Novavax to buy it.
The correlation of Novavax is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Novavax moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Novavax moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Novavax can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Novavax position
In addition to having Novavax in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Strategy ETFs Thematic Idea Now
Strategy ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Strategy ETFs theme has 1274 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Strategy ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Novavax Stock Analysis
When running Novavax's price analysis, check to measure Novavax's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Novavax is operating at the current time. Most of Novavax's value examination focuses on studying past and present price action to predict the probability of Novavax's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Novavax's price. Additionally, you may evaluate how the addition of Novavax to your portfolios can decrease your overall portfolio volatility.